CD209 and gastric cancer: In vitro results have shown that downregulation of DC-SIGN significantly inhibits the proliferation, cell cycle progression, migration and invasion of gastric cancer cells (123), suggesting that the expression level of DC-SIGN correlates positively with the occurrence and development of gastric cancer.